Clinical Trial Update: UNGF Assessment in Patients With Detrusor Overactivity Undergoing Sacral Neuromodulation

View source ↗

Summary

The clinical trial evaluating UNGF assessment in detrusor overactivity patients undergoing sacral neuromodulation has completed. It was sponsored by Northwell H…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Detrusor Overactivity

Snippet

Sponsor: Northwell Health | Conditions: Detrusor Overactivity | Status: COMPLETED